Achievements
- Earned PhD in Bioinnovation from Tulane University in 2018
- Co-founded Instapath in W19, Y Combinator batch, to revolutionize cancer diagnosis
- Developed slide-free tissue imaging tech for faster, more accurate cancer detection
- Serves as Chief Clinical Officer and COO at Instapath, leading product and clinical integration
- Secured federal and state research funding to support innovative pathology solutions
- On the board and owns equity in Instapath, pushing digital pathology forward
All about David Tulman
Okay listen, let me give you the rundown on David Tulman. This guy’s a straight-up tech and biotech nerd who’s been crushing it in the startup game and science world. So, he jumped into the scene back at Ohio State, studying biology, nothing fancy, just your typical bio geek stuff. But he didn’t stop there. Dude went all in, got his PhD in Bioinnovation from Tulane, which is basically like blending biology with crazy tech to make real-world impact.
He started out as a research assistant at Ohio State, just grinding in the medical center, soaking up how things actually work in hospitals. Then, he jumped into the startup scene at the New Orleans BioInnovation Center as a commercialization intern. That’s where he got a taste for turning science into real products that can actually change lives.
Fast forward, he co-founded Instapath in W19, yeah, the Y Combinator batch. This ain’t just another digital health startup; these guys are trying to change how cancer gets diagnosed. Instead of waiting days with traditional slides, they’re building crazy-fast, slide-free tissue imaging tech. Think about that, saving lives by making cancer detection faster, more accurate, and less bullshit. That’s the kind of thing that gets you excited.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herHe’s not just a founder, he’s the Chief Clinical Officer and COO, which means he’s the guy making sure all that science actually works in the real world. He’s also on the board, owns equity, and has pulled in federal and state research funds. The dude’s legit, pushing the boundaries of digital pathology and getting funded by the big guys.
What’s wild is how his process shows he’s all about pushing innovation forward. From Ohio State to Tulane to YC, he’s been about taking raw science and turning it into something that can actually save lives. He’s based in Philly now, but he’s all about that mission to modernize healthcare.
Bottom line: David Tulman’s the real deal. A scientist turned startup founder who’s laser-focused on making cancer diagnosis faster and better. He’s the type of guy who sees a problem, jumps in, and figures out how tech can fix it, no bullshit, just results.

Select your comment type:
If something is wrong about David Tulman, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)